Calixa Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
Calixa Therapeutics, Inc. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include Z and ZERBAXA. The owner is based in Lexington, MA.
65 Hayden Avenue
Lexington, MA 02421
Showing of trademarks Trademarks
Trademark Classifications
Calixa Therapeutics, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Calixa Therapeutics, Inc. have?
Calixa Therapeutics, Inc. has 13 U.S. trademarks filed with the USPTO. Of these, 3 registered, 9 abandoned, 1 cancelled.
What trademark classes does Calixa Therapeutics, Inc. file in?
Calixa Therapeutics, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Calixa Therapeutics, Inc.'s most well-known trademarks?
Calixa Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as Z and ZERBAXA. These are among 3 currently registered trademarks in the portfolio.
What is Calixa Therapeutics, Inc.'s trademark registration success rate?
Calixa Therapeutics, Inc. has a 23% trademark registration rate, with 3 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.